Hydroxyurea induced dermatomyositis-like eruption.

Australas J Dermatol

Mater Misericordiae Hospital, Department of Dermatology, Brisbane, QLD 4101, Australia.

Published: August 2012

Medication-induced dermatomyositis (DM) is rare, but a recent review highlighted hydroxyurea (HU) as the most common inciting agent. To aid diagnosis, HU-induced DM-like eruption (HU DM-LE) forms a distinct dermopathy where the typical cutaneous features of DM are without systemic involvement and co-exist with other HU-induced cutaneous findings such as severe xerosis, atrophy, stomatitis, cutaneous and mucosal ulceration and melanonychia. On cessation of HU the DM-LE clears avoiding unnecessary immunosuppression and demonstrating the importance of consideration of medication aetiology in DM presentations. We present a case report and review of the literature.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-0960.2011.00774.xDOI Listing

Publication Analysis

Top Keywords

hydroxyurea induced
4
induced dermatomyositis-like
4
dermatomyositis-like eruption
4
eruption medication-induced
4
medication-induced dermatomyositis
4
dermatomyositis rare
4
rare review
4
review highlighted
4
highlighted hydroxyurea
4
hydroxyurea common
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!